Winning in direct-to-patient healthcare starts with brand

Direct-to-consumer healthcare companies, increasingly described as direct-to-patient (DTP), are competing on convenience. The problem is that convenience is no longer a differentiator.

The category is growing fast. Patients can now get prescriptions, weight-loss therapies, lab testing, condition-specific support, and really anything you can dream of through apps and subscriptions. Many of those options look nearly identical.

When a category transitions from disruption to parity, the decision criteria changes from “Which is the most convenient?” to “Who can I believe will give me the best value?”

Patients choose and value the company (and brand) they trust. Trust comes from a brand that delivers upon, or exceeds, expectations, every time and at every point in their journey.

Patients aren’t buying prescriptions, they’re buying confidence

Convenience used to be the only requirement for DTC healthcare. Skip the waiting room and the pharmacy line. Get your prescription filled from the couch. For a few years, that was enough of a differentiator.

That is no longer the case, and the reason is what BCG calls “consumer contagion.” Patients judge a DTP company by the standards of their everyday lives as consumers, set by the grocery order that showed up within the hour and the flight they rebooked in a couple of taps. Speed and ease are now the minimum bar a DTP brand must clear just to be considered. But they’re not differentiators.

Yet healthcare decisions carry a weight that grocery orders don’t. A patient choosing a DTP provider is deciding who to believe about their health, often without meeting a clinician in person.

The questions underneath that component of choice are not about speed. Consumers want to know is this treatment right for me? Can I trust what I’m being told? Who is actually behind this app, and what happens if something goes wrong?

Brand is where those answers live.

Lost trust drives patients to leave

In Monigle’s Humanizing Brand Experience: Healthcare edition, Vol. 9, a quarter of surveyed consumers reported switching healthcare providers after losing trust in them.

While that research studied traditional healthcare organizations and hospital systems rather than DTP models, it shows how important trust is to consumers when it comes to decisions about their health.

Without a long-standing clinician relationship or physical location, A DTP patient has far less tying them to a brand. It’s reasonable to expect trust-driven switching to hit DTP companies at least as hard, probably harder. BCG makes the same case in its analysis of the category, advising DTP companies to “treat trust as the foundation, not a feature.”

More information has made patients less certain

Patients now arrive at care having done their own research. A CDC survey found that more than half of U.S. adults went online to look up health or medical information over the course of a year.  Yet all that research hasn’t produced confidence in their providers. Edelman’s 2026 Trust Barometer special report on health and trust found that the share of people who feel confident making their own health decisions fell ten points in one year, from 61% to 51%.

So, patients are more self-directed and less sure of themselves at the same time, which means they are constantly in search of signals that confirm they are making the right decisions about their care.

Since much of the clinical work happens out of sight, patients judge the company by whether its promises hold up. A patient who spent the week reading conflicting advice online wants to hear one consistent explanation from the company’s website, its clinician, and its follow-up messages. If the site promises a personalized plan and the clinician’s notes read like a template, the patient starts doubting the company, and their own decision along with it. That seamless experience between promise and delivery carries much of the credibility that a waiting room and a white coat used to carry.

Three brand mandatories for building trust in DTP

For a DTP company, trust comes down to three brand mandatories, each tied to a different stage of the patient’s relationship with the brand.

1. Build trust before asking for commitment

DTP companies ask for a lot before a patient has much reason to trust them. In a typical sign-up flow, a patient hands over their medical history and payment details before learning who will even review their case.

The brand must do the work to instill enough trust before the patient is asked to provide that information. A patient who hasn’t experienced the care yet judges the company’s trustworthiness by how it presents itself, because they don’t have much else to go off of. They will notice what the brand chooses to emphasize and how candid it is about tradeoffs, and they can tell whether it seems more interested in treating them or converting them.

Building trust before commitment means treating every touch point before enrollment as a brand decision, so the brand earns the belief the sign-up flow is about to ask for.

2. Design a connected experience

To a patient, the website, the clinical intake, the pharmacy fulfillment, and the follow-up text all come from one company, even if four different teams built them. Trust can be won or lost at any of those points, and if they don’t reinforce each other, that trust will break.

A polished acquisition experience won’t make up for confusing onboarding. A strong provider visit won’t survive a support team that contradicts it. A cohesive and well communicated brand gives the teams in charge of each touch point a common standard for how the company should show up, which is what lets the journey feel like one experience to the patient. That consistency is what turns a first interaction into loyalty. Every follow-up that matches what the company promised gives a patient one less reason to try a competitor.

3. Stand for something beyond convenience

Fast access, home delivery, and a clean app will keep a DTP company in the running. But they won’t make them memorable.

Patients remember companies that stand for something larger. The purpose has to be both expressed in how the brand appears and built into operations, so a patient feels it in a refill reminder as clearly as in a campaign.

Familiar names are raising the bar for trust

Some of the most familiar names in health and retail now compete directly for the same patients. Drugmakers including Eli Lilly and Pfizer run their own direct-to-patient platforms, and Amazon offers virtual care through One Medical alongside its own pharmacy. These companies bring scale alongside trust that a DTP startup has to build from scratch.

That raises the bar for everyone else. A patient already familiar with the brand starts with a level of belief a newer brand has to earn one interaction at a time.

Matching those companies on access won’t suffice. Patients will default to the name they already trust unless a DTP brand gives them a clear reason to believe in it instead.

But a newer company does have one thing working for it. It can build that trust around the specific patients it serves, in a way a company selling everything to everyone can’t. Scale may win a patient’s first look, but brand will win their loyalty for the long haul.